Clinical Study on the Safety and Efficacy of CD7 CAR-T Cell Sequential Allo-HSCT and Kidney Transplantation in the Treatment of SIOD

NCT06769191 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

RECRUITING

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Schimke Immuno-osseous Dysplasia

Interventions

BIOLOGICAL: CD7 CAR-T cells injection
PROCEDURE: Allo-HSCT
PROCEDURE: Kidney Transplantation

Sponsor

Zhejiang University

Collaborators

[object Object]